NCT07671482 Effects of Kinesio Taping Versus McConnell Taping on Clinical Outcomes in Patients With Patellofemoral Pain Syndrome.
| NCT ID | NCT07671482 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Patello Femoral Pain Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2026-06 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2026-06 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary goal of this randomized clinical trial (RCT) is to evaluate whether Kinesio Taping versus McConnell Taping, when integrated into a standardized hip-knee strengthening and neuromuscular control program, produces significant effects in individuals aged 18-50 with patellofemoral pain syndrome (PFPS). The main question it aims to answer is: Does Kinesio Taping compared with McConnell Taping when both combined with a standardized hip-knee exercise program, produce different effects on quadriceps neuromuscular activation (VMO-VL sEMG), pain, functional knee pain, and dynamic knee valgus over a 6 week period intervention? Participants will be divided into three groups for comparison: the control group will receive a structured hip-knee physical therapy exercise program without any taping intervention, Kinesio Taping group with a standardized exercise program, and a McConnell Taping group with a standardized exercise program.
Eligibility Criteria
Inclusion Criteria: * Anterior or retropatellar pain for a minimum of 3 months during functional activities. * 18-50 years of age. * Minimum pain of 3/10 on the VAS score. * No LL physical therapy in the past 3 months. Exclusion Criteria: * Meniscal or ligamentous injury * Neurological or systemic conditions affecting proprioception, coordination and balance. * Spinal referred pain or rheumatoid arthritis. * Hip and ankle disorders.
Contact & Investigator
Ahmed El Melhat, PhD
STUDY DIRECTOR
Cairo University
Frequently Asked Questions
Who can join the NCT07671482 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Patello Femoral Pain Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07671482 currently recruiting?
Yes, NCT07671482 is actively recruiting participants. Contact the research team at ahmed.elmelhat@cu.edu.eg for enrollment information.
Where is the NCT07671482 trial being conducted?
This trial is being conducted at Beirut, Lebanon.
Who is sponsoring the NCT07671482 clinical trial?
NCT07671482 is sponsored by Cairo University. The principal investigator is Ahmed El Melhat, PhD at Cairo University. The trial plans to enroll 80 participants.